MedPath

Albert Einstein College of Medicine

🇺🇸United States
Ownership
-
Established
1955-01-01
Employees
1.9K
Market Cap
-
Website
http://einstein.yu.edu

Artificially Sweetened Beverage Feeding Study

Not Applicable
Withdrawn
Conditions
Cardiovascular Disease
Interventions
Other: ASB Feeding Study
First Posted Date
2020-02-06
Last Posted Date
2020-04-24
Lead Sponsor
Albert Einstein College of Medicine
Registration Number
NCT04258345

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Phase 2
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Radiation: IGRT 45 Gy in 5 fractions of 9 Gy
Radiation: IGRT 24 Gy single dose
Drug: Dexamethasone
Drug: Tamsulosin
First Posted Date
2019-11-01
Last Posted Date
2024-06-11
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
30
Registration Number
NCT04147806
Locations
🇺🇸

Montefiore Medical Center - Moses Campus, Bronx, New York, United States

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program

Not Applicable
Active, not recruiting
Conditions
Type 2 Diabetes
Pre-Diabetes
Interventions
Other: Men-Tailored DPP (Power-Up)
First Posted Date
2019-09-26
Last Posted Date
2024-02-07
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
301
Registration Number
NCT04104243
Locations
🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease

Completed
Conditions
Inflammatory Bowel Diseases
Interventions
Diagnostic Test: Stool collection
Diagnostic Test: Biopsy collection
First Posted Date
2019-09-13
Last Posted Date
2019-09-16
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
43
Registration Number
NCT04089501
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

Phase 4
Completed
Conditions
Menopause Related Conditions
Menopause
Atrophic Vaginitis
Aging
HIV Infection
Vaginal Atrophy
Dysbiosis
Vaginitis
Premature Aging
Interventions
First Posted Date
2019-09-06
Last Posted Date
2024-02-02
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
51
Registration Number
NCT04079218
Locations
🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

Telehealth Behavioral Migraine Management

Not Applicable
Active, not recruiting
Conditions
Migraine
Interventions
Behavioral: Telehealth Behavioral Migraine Management
First Posted Date
2019-06-11
Last Posted Date
2024-10-11
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
20
Registration Number
NCT03982316
Locations
🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Phase 2
Terminated
Conditions
Pancreatic Cancer
Interventions
Drug: Gemcitabine
Biological: TT vaccine booster
First Posted Date
2019-02-20
Last Posted Date
2024-04-18
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
10
Registration Number
NCT03848182
Locations
🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

5-Cog Battery for Detecting Cognitive Impairment and Dementia

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Dementia
Cognitive Impairment
Neurocognitive Disorders
Interventions
Other: 5-Cog
Other: Health Literacy & Grip Assessment
First Posted Date
2019-01-25
Last Posted Date
2024-01-09
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
1201
Registration Number
NCT03816644
Locations
🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

2-A-Day Study: Twice a Day Meals Study.

Not Applicable
Completed
Conditions
PreDiabetes
Interventions
Other: Ad libitum meal timing
Other: Twice a day meals
First Posted Date
2019-01-18
Last Posted Date
2024-02-13
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
60
Registration Number
NCT03809299
Locations
🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)

Phase 2
Withdrawn
Conditions
Pain
Interventions
Device: Oculus
Device: Google Cardboard
Drug: Lidocaine Hydrochloride
Drug: Bupivacaine
First Posted Date
2018-12-26
Last Posted Date
2021-01-14
Lead Sponsor
Albert Einstein College of Medicine
Registration Number
NCT03787147
© Copyright 2025. All Rights Reserved by MedPath